Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why the Navi Launch Is So Important for Advanced Micro Devices Stock

By Chris Lau, InvestorPlace Contributor

Advanced Micro Devices is rumored to announce Navi in the coming weeks. Here's why Navi is vital to AMD stock's comeback story.

Shopify Earnings Preview: Is Now a Good Time to Buy?

By Chris Lau, InvestorPlace Contributor

Investors are highly confident in Shopify stock ahead of the company's earnings report on April 30. What are they expecting from that report?

Why Is Bristol-Myers Near 52-Week Lows?

By Chris Lau, InvestorPlace Contributor

Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.

Why Investors Should Avoid CenturyLink for Now

By Chris Lau, InvestorPlace Contributor

CenturyLink is in the dog house after the dividend cut. The short-term pressure on CTL stock is strong, but longer-term prospects are better.

5 Semiconductor Stocks to Buy for a Spring Charge

By Chris Lau, InvestorPlace Contributor

Spring is blooming and so are semiconductor stocks. Qualcomm re-ignited the buying in this space. Now, it's time for investors to look.

Load More